We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DOMO:NASDAQDomo, Inc. Analysis

Data as of 2026-03-29 - not real-time

$3.10

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Domo, Inc. (DOMO) is trading at $3.10, well below its 20‑day ($3.99) and 50‑day ($4.63) simple moving averages, with the price sitting near the identified support of $3.06 and far under the DCF‑derived fair value of $16.76, suggesting a substantial upside potential. The RSI of 33 points to oversold conditions, while a bearish MACD histogram reinforces short‑term downside pressure, and the stock’s 30‑day volatility exceeds 110% with a beta of 1.68, indicating a highly volatile, high‑beta profile.
On the fundamentals side, Domo posted record quarterly billings of $111.2 million (up 8% YoY) and improved retention, yet it still reports negative operating margins (‑9%) and a trailing EPS of –$1.45, though forward EPS is projected at $0.14. The company announced a new partnership with Nine Entertainment and a major product upgrade, and it is actively exploring strategic alternatives to unlock value. Despite a modest revenue growth of 1.1% and a negative book value per share, free cash flow is positive at $57 million, and analysts maintain a “buy” consensus with median price targets around $7, highlighting the perceived valuation gap.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering at technical support with oversold RSI
  • Bearish MACD and decreasing volume indicating downside pressure
  • Recent partnership and product upgrade could provide short‑term catalyst

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation upside versus DCF fair value
  • Record billings and improving retention suggest revenue momentum
  • Exploration of strategic alternatives may unlock shareholder value

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Long‑term demand for AI‑driven data platforms in enterprise markets
  • Positive free cash flow despite negative earnings
  • Analyst consensus and price targets indicating upside potential

Key Metrics & Analysis

Financial Health

Revenue Growth1.10%
Profit Margin-18.61%
P/E Ratio22.8
ROA-9.98%
P/B Ratio-0.7
Op. Cash Flow$7.9M
Free Cash Flow$57.2M
Industry P/E32.0

Technical Analysis

TrendBearish
RSI33.3
Support$3.06
Resistance$6.24
MA 20$3.99
MA 50$4.63
MA 200$11.09
MACDBearish
VolumeDecreasing
Fear & Greed Index65.98

Valuation

Fair Value$16.76
Target Price$6.20
Upside/Downside100.00%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.68
Volatility112.92%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.